The former Bio-Rad Laboratories general counsel has urged the court to deny Bio-Rad’s motion to dismiss his suit brought under the Sarbanes-Oxley Act, 15 U.S.C. § 1514A (“SOX”).  See Wadler v. Bio-Rad Labs., Inc., No. 15-cv-02356 (N.D. Cal. Aug. 11, 2015), ECF Nos. 35, 50.  The former general counsel alleged that he was terminated in retaliation for uncovering evidence of widespread bribery and other FCPA violations concerning Bio-Rad’s operations in China, and in opposing the motion to dismiss.  He argued that Bio-Rad did not attempt to dispute that he stated a valid claim under SOX but rather made self-serving and unsupported arguments in an effort to seek to have the individual directors named in the suit dismissed.  The court granted the SEC’s Motion to File Amicus Brief in Support of Plaintiff, which argued that the former general counsel is covered by its August 4, 2014 decree, that whistleblowers who only report misconduct within their companies must nonetheless be protected.